Cargando…
Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients
Severe cases of COVID-19 are characterized by a strong inflammatory process that may ultimately lead to organ failure and patient death. The NLRP3 inflammasome is a molecular platform that promotes inflammation via cleavage and activation of key inflammatory molecules including active caspase-1 (Cas...
Ejemplares similares
-
Gasdermin-D activation promotes NLRP3 activation and host resistance to Leishmania infection
por: de Sá, Keyla S. G., et al.
Publicado: (2023) -
Infection of human lymphomononuclear cells by SARS-CoV-2
por: Pontelli, Marjorie C, et al.
Publicado: (2020) -
Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory functions and clearance of apoptotic cells
por: Salina, Ana CG, et al.
Publicado: (2022) -
Identification of immunomodulatory drugs that inhibit multiple inflammasomes and impair SARS-CoV-2 infection
por: de Almeida, Letícia, et al.
Publicado: (2022) -
SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients
por: Pontelli, Marjorie C, et al.
Publicado: (2022)